Access problems plague both peritoneal dialysis and hemodialysis

Area of Science:

• Nephrology
• Medical Technology
• Patient Safety

Background:

• Chronic kidney disease management necessitates long-term dialysis therapies, including peritoneal dialysis (PD) and center hemodialysis (HD).
• Both PD and HD rely on transcutaneous access, posing substantial costs and complication risks.
• Access-related complications significantly impact the safety and acceptability of these life-sustaining treatments.

Purpose of the Study:

• To compare the complication rates and severity between vascular access in hemodialysis and peritoneal access in peritoneal dialysis.
• To evaluate the clinical and economic implications of access-related issues in both chronic dialysis modalities.

Main Methods:

• Comparative analysis of complication data from existing studies on PD and HD access.
• Review of reported rates for exit site infections, peritonitis, and blood access clotting.
• Assessment of treatment modalities and outcomes, including hospitalization and surgical interventions.

Main Results:

• Exit site infections (PD) and blood access clotting (HD) present comparable complication frequencies.
• Peritoneal dialysis access complications, though potentially more frequent overall, are often managed outpatient.
• Hemodialysis vascular access complications carry a higher risk of bacteremia, sepsis, and necessitate surgical revision.

Conclusions:

• Both PD and HD face significant access challenges that require ongoing efforts for improvement.
• Reducing access complications can enhance the overall safety and patient acceptance of both dialysis modalities.
• Understanding the differential severity of access complications is crucial for optimizing patient care in chronic dialysis.